National Institutes of Health: Neurologic Manifestations trials
The registry lists 13 Neurologic Manifestations studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 2Phase 2 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Carboplatin and Bevacizumab for Recurrent EpendymomaCompletedNCT01295944Phase 2Results posted
- Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in LiberiaCompletedNCT06811129
- An Observational Study of Neurologic Function After COVID-19 InfectionCompletedNCT04564287
- Mechanisms of Diabetic Kidney Disease in American IndiansCompletedNCT01878045
- Physiological Investigations of Movement DisordersCompletedNCT01019343Not applicable
- Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft SurgeryTerminatedNCT00123539Not applicable
- Outcomes of Sleep Disorders in Older MenCompletedNCT00070681
- New CVD Risk Factors for Lowered Cognitive FunctioningCompletedNCT00037310
- Age, Risk Factors for CVD and Cognitive FunctioningCompletedNCT00007397
- Study of Brain Changes Shaped by ExperienceCompletedNCT00006424
- Neuropsychological Studies of Children With Sickle CellCompletedNCT00005438
- Infrared Camera for Brain Mapping During SurgeryCompletedNCT00001554Phase 1
- Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1CompletedNCT00000738Phase 1